Asia-Pacific Neuromodulation Devices Market Outlook to 2025

GlobalData
99 Pages - GLDATA65699
$5,995.00

Summary

GlobalData’s new report, Asia-Pacific Neuromodulation Devices Market Outlook to 2025, provides key market data on the Asia-Pacific Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Neuromodulation Devices market.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Neuromodulation Devices market.
- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.



Companies Mentioned
Medtronic Plc
Boston Scientific Corp
Nevro Corp
LivaNova PLC
Abbott Healthcare Pvt Ltd

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Neuromodulation Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Neuromodulation Devices Market, Asia-Pacific 8
3.1 Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), 2015-2025 8
3.2 Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), 2015-2025 10
3.3 Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2015-2025 13
3.4 Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2015-2025 15
3.5 Neuromodulation Devices Market, Asia-Pacific, Company Share by Revenue ($m), 2017 18
4 Neuromodulation Devices Market, Australia 20
4.1 Neuromodulation Devices Market, Australia, Revenue ($m), 2015-2025 20
4.2 Neuromodulation Devices Market, Australia, Volume (Units), 2015-2025 23
4.3 Neuromodulation Devices Market, Australia, Average Price ($), 2015-2025 26
4.4 Neuromodulation Devices Market, Australia, Distribution Share by Revenue ($m), 2017 28
4.5 Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2017 29
5 Neuromodulation Devices Market, China 31
5.1 Neuromodulation Devices Market, China, Revenue ($m), 2015-2025 31
5.2 Neuromodulation Devices Market, China, Volume (Units), 2015-2025 34
5.3 Neuromodulation Devices Market, China, Average Price ($), 2015-2025 37
5.4 Neuromodulation Devices Market, China, Distribution Share by Revenue ($m), 2017 39
5.5 Neuromodulation Devices Market, China, Company Share by Revenue ($m), 2017 40
6 Neuromodulation Devices Market, India 42
6.1 Neuromodulation Devices Market, India, Revenue ($m), 2015-2025 42
6.2 Neuromodulation Devices Market, India, Volume (Units), 2015-2025 45
6.3 Neuromodulation Devices Market, India, Average Price ($), 2015-2025 48
6.4 Neuromodulation Devices Market, India, Distribution Share by Revenue ($m), 2017 50
6.5 Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2017 51
7 Neuromodulation Devices Market, Japan 53
7.1 Neuromodulation Devices Market, Japan, Revenue ($m), 2015-2025 53
7.2 Neuromodulation Devices Market, Japan, Volume (Units), 2015-2025 56
7.3 Neuromodulation Devices Market, Japan, Average Price ($), 2015-2025 59
7.4 Neuromodulation Devices Market, Japan, Distribution Share by Revenue ($m), 2017 61
7.5 Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2017 62
8 Neuromodulation Devices Market, South Korea 64
8.1 Neuromodulation Devices Market, South Korea, Revenue ($m), 2015-2025 64
8.2 Neuromodulation Devices Market, South Korea, Volume (Units), 2015-2025 67
8.3 Neuromodulation Devices Market, South Korea, Average Price ($), 2015-2025 70
8.4 Neuromodulation Devices Market, South Korea, Distribution Share by Revenue ($m), 2017 72
8.5 Neuromodulation Devices Market, South Korea, Company Share by Revenue ($m), 2017 73
9 Overview of Key Companies in Asia-Pacific Neuromodulation Devices Market 75
9.1 Medtronic Plc 75
9.1.1 Company Overview 75
9.2 Boston Scientific Corp 75
9.2.1 Company Overview 75
9.3 Nevro Corp 75
9.3.1 Company Overview 75
9.4 LivaNova PLC 76
9.4.1 Company Overview 76
9.5 Abbott Healthcare Pvt Ltd 76
9.5.1 Company Overview 76
10 Neuromodulation Devices Market Pipeline Products 77
11 Recent Developments 82
11.1 Corporate Communications 82
11.1.1 Jul 04, 2018: Neurotech International Appoints Dr. David Cantor To Board 82
11.1.2 Jun 28, 2018: NeuroTech International: Retirement of Dr Adrian Attard Trevisan 82
11.1.3 Jun 21, 2018: Fisher & Paykel Healthcare announces new Future Director appointment 83
11.1.4 Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director 83
11.1.5 Feb 21, 2018: Fisher & Paykel Healthcare Announces Retirement Of Tony Barclay As CFO 83
11.1.6 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 84
11.1.7 Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice 84
11.2 Financial Announcements 85
11.2.1 May 28, 2018: Fisher & Paykel Healthcare Announces Record Full Year Result 85
11.2.2 May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018 86
11.2.3 Nov 21, 2017: Strong Half Year Result from Fisher & Paykel Healthcare: Record Net Profit of NZ$81.3 Million 88
11.3 Legal And Regulatory 89
11.3.1 Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified 89
11.4 Other Significant Developments 90
11.4.1 Jan 30, 2018: Neurotech International: Quarterly report for the period ending 31 December 2017 90
11.5 Strategy And Business Planning 91
11.5.1 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 91
11.5.2 Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya 91
12 Appendix 93
12.1 Research Methodology 94
12.1.1 Coverage 94
12.1.2 Secondary Research 94
12.1.3 Primary Research 95
12.1.4 Market Modeling and Forecasting 96
12.1.5 Company Share Analysis 97
12.1.6 Distribution Share Analysis 98
12.1.7 Benchmarking 98
12.2 GlobalData Consulting 98
12.3 Contact Us 99
12.4 Disclaimer 99

1.1 List of Tables
Table 1: Neuromodulation Devices Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2015-2025 9
Table 2: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2015-2020 11
Table 3: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2021-2025 12
Table 4: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2015-2025 14
Table 5: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2015-2020 16
Table 6: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2021-2025 17
Table 7: Neuromodulation Devices Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2017 19
Table 8: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2015-2020 21
Table 9: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2021-2025 22
Table 10: Neuromodulation Devices Market, Australia, Volume (Units), 2015-2020 24
Table 11: Neuromodulation Devices Market, Australia, Volume (Units), 2021-2025 25
Table 12: Neuromodulation Devices Market, Australia, Average Price ($), 2015-2020 26
Table 13: Neuromodulation Devices Market, Australia, Average Price ($), 2021-2025 27
Table 14: Neuromodulation Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 28
Table 15: Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 30
Table 16: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2015-2020 32
Table 17: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2021-2025 33
Table 18: Neuromodulation Devices Market, China, Volume (Units), 2015-2020 35
Table 19: Neuromodulation Devices Market, China, Volume (Units), 2021-2025 36
Table 20: Neuromodulation Devices Market, China, Average Price ($), 2015-2020 37
Table 21: Neuromodulation Devices Market, China, Average Price ($), 2021-2025 38
Table 22: Neuromodulation Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 39
Table 23: Neuromodulation Devices Market, China, Company Share by Revenue ($m), USD Constant, 2017 41
Table 24: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2015-2020 43
Table 25: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2021-2025 44
Table 26: Neuromodulation Devices Market, India, Volume (Units), 2015-2020 46
Table 27: Neuromodulation Devices Market, India, Volume (Units), 2021-2025 47
Table 28: Neuromodulation Devices Market, India, Average Price ($), 2015-2020 48
Table 29: Neuromodulation Devices Market, India, Average Price ($), 2021-2025 49
Table 30: Neuromodulation Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 50
Table 31: Neuromodulation Devices Market, India, Company Share by Revenue ($m), USD Constant, 2017 52
Table 32: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2015-2020 54
Table 33: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2021-2025 55
Table 34: Neuromodulation Devices Market, Japan, Volume (Units), 2015-2020 57
Table 35: Neuromodulation Devices Market, Japan, Volume (Units), 2021-2025 58
Table 36: Neuromodulation Devices Market, Japan, Average Price ($), 2015-2020 59
Table 37: Neuromodulation Devices Market, Japan, Average Price ($), 2021-2025 60
Table 38: Neuromodulation Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2017 61
Table 39: Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2017 63
Table 40: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2015-2020 65
Table 41: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2021-2025 66
Table 42: Neuromodulation Devices Market, South Korea, Volume (Units), 2015-2020 68
Table 43: Neuromodulation Devices Market, South Korea, Volume (Units), 2021-2025 69
Table 44: Neuromodulation Devices Market, South Korea, Average Price ($), 2015-2020 70
Table 45: Neuromodulation Devices Market, South Korea, Average Price ($), 2021-2025 71
Table 46: Neuromodulation Devices Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 72
Table 47: Neuromodulation Devices Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 74
Table 48: Neuromodulation Devices Market Pipeline Products 77
Table 49: Total Number of Primary Research Participants, Neurology Devices Market, by Country 96

1.2 List of Figures
Figure 1: Neuromodulation Devices Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2015-2025 8
Figure 2: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2015-2025 10
Figure 3: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2015-2025 13
Figure 4: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2015-2025 15
Figure 5: Neuromodulation Devices Market, Asia-Pacific, Company Share (%) 2017 18
Figure 6: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2015-2025 20
Figure 7: Neuromodulation Devices Market, Australia, Volume (Units), 2015-2025 23
Figure 8: Neuromodulation Devices Market, Australia, Company Share (%) 2017 29
Figure 9: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2015-2025 31
Figure 10: Neuromodulation Devices Market, China, Volume (Units), 2015-2025 34
Figure 11: Neuromodulation Devices Market, China, Company Share (%) 2017 40
Figure 12: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2015-2025 42
Figure 13: Neuromodulation Devices Market, India, Volume (Units), 2015-2025 45
Figure 14: Neuromodulation Devices Market, India, Company Share (%) 2017 51
Figure 15: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2015-2025 53
Figure 16: Neuromodulation Devices Market, Japan, Volume (Units), 2015-2025 56
Figure 17: Neuromodulation Devices Market, Japan, Company Share (%) 2017 62
Figure 18: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2015-2025 64
Figure 19: Neuromodulation Devices Market, South Korea, Volume (Units), 2015-2025 67
Figure 20: Neuromodulation Devices Market, South Korea, Company Share (%) 2017 73

$5,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports